Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria.
about
Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis.Current status of lupus nephritis.Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohortJoint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.Taming lupus-a new understanding of pathogenesis is leading to clinical advances.New treatment strategies for proliferative lupus nephritis: keep children in mind!Treatment of proliferative lupus nephritis: a slowly changing landscape.Recent advances in the treatment of lupus nephritis.Overview of lupus nephritis management guidelines and perspective from Asia.Overview of lupus nephritis management guidelines and perspective from Asia.Treatment of severe lupus nephritis: the new horizon.Renin-Angiotensin system inhibitors reduce serum asymmetric dimethylarginine levels and oxidative stress in normotensive patients with chronic kidney disease.[Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis].New perspectives and insights to Asian systemic lupus erythematosus: renal disease, genetic predisposition and disease activity.
P2860
Q33806541-D2970255-7B63-4D43-BF51-09633FC65B25Q33882751-1D9A0C34-5145-48DD-BE00-876CE8596EDEQ34044918-5AF4B591-73D7-4B22-8F0C-AD19E8016091Q36302245-C19C152C-82D7-4D64-BCF0-E27A338FABE8Q36712941-E4BDCAC4-116C-4CBE-AAC6-30FFD663ECC6Q36915693-8AB12C1B-53B1-4717-AA6F-D7E9D70A6B8FQ37822658-EC840CE0-B3B0-4599-A950-1A160FEEC514Q37953243-78F891C8-3578-4701-8684-7602D989C38DQ38123242-707BB707-C299-4CFC-8161-CCA02A571942Q38175076-040A200C-8707-45D1-8F6C-56ACC90B7488Q38271125-C8693C18-BB89-4DF0-99BF-1161C2E96CC6Q38629539-149A4A33-BF3E-454B-9A79-5CF70729CCB0Q41540102-47CA8A4B-CA62-4988-A985-34F813D8B51EQ43626306-CEAF9207-74A1-4FB4-BC71-34303C02DFF7
P2860
Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Angiotensin inhibition or bloc ...... is and persistent proteinuria.
@en
Angiotensin inhibition or bloc ...... is and persistent proteinuria.
@nl
type
label
Angiotensin inhibition or bloc ...... is and persistent proteinuria.
@en
Angiotensin inhibition or bloc ...... is and persistent proteinuria.
@nl
prefLabel
Angiotensin inhibition or bloc ...... is and persistent proteinuria.
@en
Angiotensin inhibition or bloc ...... is and persistent proteinuria.
@nl
P2093
P2860
P1433
P1476
Angiotensin inhibition or bloc ...... is and persistent proteinuria.
@en
P2093
P2860
P304
P356
10.1191/0961203305LU2249OA
P577
2005-01-01T00:00:00Z